Serotypes, genotypes, and antibiotic susceptibility profiles of group B streptococci causing neonatal sepsis and meningitis before and after introduction of antibiotic prophylaxis

Pediatric Infectious Disease Journal

Volumn 25, Issue 10, 2006, Pages 945-948

  Trijbels Smeulders, Monique A J M ^a,b   Kimpen, Jan L L ^c   Kollée, Louis A A ^a   Bakkers, Judith ^a   Melchers, Willem ^a   Spanjaard, Lodewijk ^d   Wannet, Wim J B ^e   Hoogkamp Korstanje, Mieke A A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Flevoziekenhuis ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Genotype; Group B streptococci; Serotype; Strains; Susceptibility

Indexed keywords

PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NETHERLANDS; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL TYPING TECHNIQUES; GENOTYPE; HUMANS; INFANT, NEWBORN; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; SEPSIS; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 33749429007     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000237821.65559.08     Document Type: Article

References (19)

1. Trijbels-Smeulders M. Group B streptococcal disease: effect of the dutch guidelines for prevention. Thesis. Radboud University Nijmegen. 2006;ISBN:90-9020576-4.
2. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15-20.
3. Benson JA, Ferrieri P. Rapid pulsed-field gel electrophoresis method for Group B streptococcus isolates. J Clin Microbiol. 2001;39:3006-3008.
4. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-2239.
5. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Eleventh Informational Supplement M110-S11, NCCLS 2001. Wayne, PA: National Committee for Clinical Laboratory Standards.
6. Hartwig NG, Kornelisse RF, Verduin CM. Blauwdruk Pediatrische Antimicrobiele Therapie. 2001.
7. Reed MD, Goldfarb J, Blumer JL. Anti-infective therapy. In: Jenson HB, Baltimore RS, eds. Pediatric Infectious Diseases: Principles and Practice. Norwalk, CT: Appleton and Lange; 1995.
8. Lutsar I, McCracken GH, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis. 1998;27:1117-1129.
9. Tauber MG, Doroshow CA, Hackbarth CJ, et al. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis. 1984;149:568-574.
10. Cutler NR, Vincent J, Jhee SS. Penetration of trovafloxacin into cerebrospinal fluid following intravenous infusion of alatrofloxacin. Antimicrob Agents Chemother. 1997;41:1298-1300.
11. Isaacs D, Slack MPE, Wilkinson AR. Successful treatment of Pseudomonas ventriculitis with ciprofloxacin. J Antimicrob Chemother. 1986;17:535-538.
12. Owens RC, Ambrose PG. Pharmacodynamics of quinolones. In: Nightingale CH, Murakawa T, Ambrose PG, eds. Antimicrobial Pharmacodynamics in Theory and Clinical Practice. New York, NY: Marcel Dekker; 2002.
13. Ambrose PG, Grasela DM, Grasela TH, et al. Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae: analysis of phase-III clinical trials. J Antimicrob Chemother. 2001;45:2793-2797.
14. Gerards LJ, Cats BP, Hoogkamp-Korstanje JAA. The influence of group B streptococcal-carriership on pregnancy outcome. J Perinat Med. 1982;10:279-284.
15. Baker CJ. Group B streptococcal infections. Clin Perinatol. 1997;24:59-70.
16. Harrison LH, Elliot JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation: Maryland Emerging Infection Program. Infect Dis. 1998;177:998-1002.
17. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1994 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother. 1998;42:1517-1519.
18. Melchers WJG, Bakkers JMJE, Toonen M, Kuppeveld FJM, Trijbels M, Hoogkamp-Korstanje JAA. Genetic analysis of Streptococcus agalactiae strains isolated from neonates and their mothers. FEMS Immunol Med Microbiol. 2003;36:111-113.
19. Hansen SM, Uldberg N, Kilian M, et al. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J Clin Microbiol. 2004;42:83-89.